Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) Recruiting Phase 2 Trials for Renal Cancers Diagnostic

IndicationsStatusPurposePhase
RecruitingDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT04021238Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging